Notice of Thai Red Cross AIDS Research Centre Subject: Thai Red Cross has ceased and no longer involves with Adam’s Love website. As of July 24th, 2018, Adam’s Love clinic, operated in partnership with the Thai Red Cross AIDS Research Centre (TRCARC), has officially ceased its operation. TRCARC is no longer involved in the Continue Reading
Strategies for the prevention of mother-to-child transmission (PMTCT) of HIV have undergone considerable evolution based on scientific evidence, both at global and local levels. Because of the rapid expansion of the HIV epidemic among the heterosexual population, and the relatively advanced mother and child health infrastructure, Thailand has been …
This is a 3D animation video clip to teach Thai children who have above 10 years old to understand that if they going to be teenager, how to have safe sex, pregnancy prevention, and sexually transmitted diseases prevention.
BANGKOK—The old saying, “You are what you eat,” doesn’t apply that well to Atachai Phunkron. It’s more about what he wears. Who would have thought a nondescript lab coat could change his life? Just ask him about it and watch him beam.
“PrEPARING ASIA: A new direction for HIV prevention among MSM in Asia” is a regional dialogue preparing the future roll-out of pre-exposure prophylaxis (PrEP) for self-identified gay men and other men who have sex with men (MSM) in Asia. Organized by APCOM with the support from UNAIDS and WHO, the dialogue will bring in representatives of
A major international clinical trial has provided the strongest evidence yet that people infected with H.I.V., the virus that causes AIDS, should get treated as soon as possible, even if they are feeling well, to ward off serious illness and fatal complications in future years. The finding raises the powerful moral question of whether global and national organizations can find the will
What is the START study? The START (“Strategic Timing of AntiRetroviral Treatment”) study is a randomized, controlled clinical trial designed to more clearly define the optimal time for HIV- infected individuals to begin antiretroviral therapy. The trial enrolled healthy, asymptomatic, HIV-infected people whose level of CD4+ T cells—a measure of immune system health—exceeded 500
From: National Institutes of Health NIH-Funded Trial Results Likely Will Impact Global Treatment Guidelines A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune system health—is higher, Continue Reading
A new study sheds light on how to halve the number of new HIV infections among men who have sex with men in Bangkok.